サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654277

肥満治療市場の市場規模、シェア、動向分析レポート：薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント予測、2025年～2030年

Obesity Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 153 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
肥満治療市場の市場規模、シェア、動向分析レポート：薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント予測、2025年～2030年
出版日: 2025年01月22日
発行: Grand View Research
ページ情報: 英文 153 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肥満治療市場の成長と動向：

世界の肥満治療市場規模は2030年に605億3,000万米ドルに達すると予測され、2025年から2030年にかけてCAGR 22.31％で成長すると予測されます。

座りがちなライフスタイル、運動不足、不健康な食習慣の増加傾向は、肥満の高蔓延を引き起こす重要な要因です。Institute of Health Metrics and Evaluationによると、世界人口の約30.0％が肥満または過体重です。

さらに、体重管理のためのソリューションが市販されるとともに、業界企業によって導入された技術的進歩や政府によって実施された支援イニシアティブが、肥満とその健康への影響に関してより多くの意識を生み出しています。これが肥満治療市場の成長をさらに促進しています。

体重管理には、食事療法、運動療法、薬物療法、低侵襲デバイス＆インプラント、手術などさまざまなアプローチがあります。一般的な薬剤の中では、配合剤が最大の市場シェアを占めていますが、満腹感をもたらす満腹剤が肥満治療市場で最も急成長している分野です。

手術では、胃バイパス術が最大の成長セグメントを形成しているのに対し、満腹感装置や胃排出装置などのインプラントや装置を外科的に設置する低侵襲内視鏡手術セグメントが最も急速に成長しています。

民間部門における激しい競合が、民間の病院や診療所で提供される肥満治療の最新技術の開発に向けて前進と革新を促しています。その結果、低侵襲手術の需要が急速に高まっています。さらに、肥満と関連疾患に対する意識の高まりと、体重管理ソリューションの市販化が肥満治療市場を後押ししています。

肥満治療市場のレポートハイライト

  • 薬剤クラスでは、GLP-1受容体作動薬、リパーゼ阻害薬、食欲抑制薬、その他の薬剤クラスに分類されます。
  • 投与経路では、肥満治療市場は非経口とオーラルに分類されます。
  • 流通チャネルでは、病院薬局、小売薬局、その他に分類されます。
  • その他薬局は予測期間中にかなりの成長が見込まれます。
  • 北米の肥満治療市場は、2024年に73.39％の収益シェアで世界の業界を制しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 肥満治療市場の変数、動向、範囲

  • 親市場の見通し
  • 補助市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 肥満治療分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 肥満治療市場：薬剤クラスの推定・動向分析

  • 肥満治療市場：薬剤クラスセグメントダッシュボード
  • 肥満治療市場：薬剤クラス別の変動分析
  • GLP-1受容体作動薬
    • セマグルチド（Wegovy）
    • リラグルチド（サクセンダ）
    • ティルゼパタイド（ゼプバウンド）
  • リパーゼ阻害剤
  • 食欲抑制剤
  • その他の薬剤クラス

第5章 肥満治療市場：投与経路の推定・動向分析

  • 肥満治療市場：投与経路セグメントダッシュボード
  • 肥満治療市場：投与経路別の変動分析
  • 非経口
  • オーラル

第6章 肥満治療市場：流通チャネルの推定・動向分析

  • 肥満治療市場：流通チャネルセグメントダッシュボード
  • 肥満治療市場：流通チャネルの変動分析
  • 病院薬局
  • 小売薬局
  • その他

第7章 肥満治療市場：地域推定・動向分析

  • 肥満治療市場シェア、地域別
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • ノルウェー
    • スウェーデン
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート
    • 南アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業市場シェア分析、2024年
  • 企業ヒートマップ分析、2024年
  • 企業プロファイル
    • Novo Nordisk A/S.
    • GSK plc.
    • VIVUS LLC
    • Currax Pharmaceuticals
    • Boehringer Ingelheim International GmbH
    • Rhythm Pharmaceuticals, Inc.
    • Gelesis
    • Eli Lilly and Company.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 4 Global Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 5 Global Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 North America Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 North America Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 11 U.S. Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Canada Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Mexico Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Mexico Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Europe Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Europe Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 24 Germany Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Germany Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 U.K. Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 27 U.K. Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 U.K. Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 30 France Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 France Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Italy Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Italy Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Italy Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Spain Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Spain Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 Spain Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Denmark Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Denmark Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 Denmark Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Sweden Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Sweden Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Sweden Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Norway Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Norway Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Norway Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 China Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 52 China Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 China Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Japan Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Japan Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Japan Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 India Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 58 India Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 India Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 South Korea Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 61 South Korea Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 62 South Korea Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Australia Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 64 Australia Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Australia Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Thailand Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Thailand Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Thailand Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Latin America Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Latin America Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Brazil Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 74 Brazil Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 Brazil Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 77 Argentina Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 Argentina Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 South Africa Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 84 South Africa Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 South Africa Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 90 UAE Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 UAE Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Obesity treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug class and route of administration segment snapshot
  • Fig. 10 Distribution channel Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook, 2024 (USD Billion)
  • Fig. 13 Bariatric surgery devices market outlook (USD Billion)
  • Fig. 14 Liposuction surgery devices market outlook (USD Billion
  • Fig. 15 Endoscopy procedures market outlook (USD Billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Obesity treatment market: Drug class outlook and key takeaways
  • Fig. 20 Obesity treatment market: Drug class movement analysis
  • Fig. 21 GLP-1 receptor agonists market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Semaglutide (Wegovy) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Liraglutide (Saxenda) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Tirzepatide (Zepbound) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Lipase inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Appetite suppressants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Other drug class market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Obesity treatment market: Route of administration outlook and key takeaways
  • Fig. 29 Obesity treatment market: Route of administration movement analysis
  • Fig. 30 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Parenteral market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Obesity treatment market: Distribution channel outlook and key takeaways
  • Fig. 33 Obesity treatment market: Distribution channel movement analysis
  • Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Obesity treatment market revenue, by region, 2024 & 2030(USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Obesity death share, 2021
  • Fig. 40 Death rate from obesity (deaths per 100000 people), 2021
  • Fig. 41 Share of obese or overweight children, 2022
  • Fig. 42 North America obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 U.S. obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Prevalence of obesity in adults aged 20 and older, by sex and age in the U.S. August 2021-Augutst 2023
  • Fig. 46 Prevalence of severe obesity in adults aged 20 and older, by sex and age in the U.S. August 2021-Auguts 2023
  • Fig. 47 Obesity prevalence across states (2023)
  • Fig. 48 Key country dynamics
  • Fig. 49 Canada obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Mexico obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Prevalence of obesity and overweight UK 2022
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Norway obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Rest of Europe obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Asia Pacific obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Obesity prevalence in South East Asia (Millions)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Australia obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Rest of Asia Pacific obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Rest of Latin America obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 MEA obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Africa obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Saudi Arabia obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Rest of MEA obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Company/competition categorization
  • Fig. 103 Company market share analysis, 2024
  • Fig. 104 Company market position analysis, 2024
  • Fig. 105 Strategy mapping
目次
Product Code: GVR-1-68038-095-8

Obesity Treatment Market Growth & Trends:

The global obesity treatment market size is expected to reach USD 60.53 billion in 2030 and is anticipated to grow at a CAGR of 22.31% from 2025 to 2030. The upward trend in sedentary lifestyles, physical inactivity, and unhealthy food habits are the vital factors responsible for the high prevalence of obesity. According to the Institute of Health Metrics and Evaluation, about 30.0% of the global population is either obese or overweight.

Additionally, along with commercial availability of solutions for weight management, technological advancements introduced by the vertical players and supportive initiatives undertaken by the governments, create more awareness with regard to obesity and its impact on health. This is further driving the growth of the obesity treatment market.

There are various approaches for weight management such as diet, exercise, drugs, minimally invasive devices & implants, and surgeries. Amongst the prevalent drugs, the combination drugs hold the largest market share whereas satiety drugs that provide a feeling of fullness appear as the fastest-growing segment in the obesity treatment market.

In surgeries, gastric bypass procedures form the largest growing segment whereas the minimally invasive endoscopic procedure segment that involves surgical placement of implants and devices, such as satiety devices and gastric emptying devices, is the fastest-growing space.

Intense competition in the private sector has driven advancements and innovation toward the development of the latest techniques for obesity treatment that are offered in private hospitals and clinics. As a result, the demand for minimally invasive procedures is swiftly increasing. In addition, increasing awareness of obesity & the associated diseases and the commercial availability of weight management solutions is propelling the obesity treatment market.

Obesity Treatment Market Report Highlights:

  • Based on drug class, the industry has been categorized into GLP-1 receptor agonists, lipase inhibitors, appetite suppressants, and other drug classes
  • Based on the route of administration, the obesity treatment market has been categorized into parenteral and oral
  • Based on distribution channels, the market has been categorized into hospital pharmacies, retail pharmacies, and others.
  • The other pharmacies are expected to grow at a considerable growth of over the forecast period
  • North America obesity treatment market dominated the global industry with a revenue share of 73.39% in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Obesity Treatment Market Variables, Trends, & Scope

  • 3.1. Parent Market Outlook
  • 3.2. Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing prevalence of obesity-related conditions
      • 3.3.1.2. Government regulations and guidelines
      • 3.3.1.3. Advancements in treatment options
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Side effects and adverse reactions
      • 3.3.2.2. High cost of anti-obesity drugs
  • 3.4. Obesity Treatment Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Obesity Treatment Market: By Drug Class Estimates & Trend Analysis

  • 4.1. Obesity Treatment Market: Drug Class Segment Dashboard
  • 4.2. Obesity Treatment Market: By Drug Class Movement Analysis, USD Million, 2024 & 2030
  • 4.3. GLP-1 Receptor Agonists
    • 4.3.1. GLP-1 Receptor Agonists Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Semaglutide (Wegovy)
      • 4.3.2.1. Semaglutide (Wegovy) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Liraglutide (Saxenda)
      • 4.3.3.1. Liraglutide (Saxenda) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Tirzepatide (Zepbound)
      • 4.3.4.1. Tirzepatide (Zepbound) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Lipase Inhibitors
    • 4.4.1. Lipase Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Appetite Suppressants
    • 4.5.1. Appetite Suppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Drug Class
    • 4.6.1. Other Drug Class Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Obesity Treatment Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Obesity Treatment Market: Route of Administration Segment Dashboard
  • 5.2. Obesity Treatment Market: By Route of Administration Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Parenteral
    • 5.3.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Obesity Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Obesity Treatment Market: Distribution Channel Segment Dashboard
  • 6.2. Obesity Treatment Market: Distribution Channel Movement Analysis, USD Million, 2024 & 2030
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Obesity Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Obesity Treatment Market Share, By Region, 2024 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Obesity Treatment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis, 2024
  • 8.5. Company Profiles
    • 8.5.1. Novo Nordisk A/S.
      • 8.5.1.1. Participant's Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Recent Developments/ Strategic Initiatives
    • 8.5.2. GSK plc.
      • 8.5.2.1. Participant's Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Recent Developments/ Strategic Initiatives
    • 8.5.3. VIVUS LLC
      • 8.5.3.1. Participant's Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Recent Developments/ Strategic Initiatives
    • 8.5.4. Currax Pharmaceuticals
      • 8.5.4.1. Participant's Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Recent Developments/ Strategic Initiatives
    • 8.5.5. Boehringer Ingelheim International GmbH
      • 8.5.5.1. Participant's Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Recent Developments/ Strategic Initiatives
    • 8.5.6. Rhythm Pharmaceuticals, Inc.
      • 8.5.6.1. Participant's Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Recent Developments/ Strategic Initiatives
    • 8.5.7. Gelesis
      • 8.5.7.1. Participant's Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Recent Developments/ Strategic Initiatives
    • 8.5.8. Eli Lilly and Company.
      • 8.5.8.1. Participant's Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Recent Developments/ Strategic Initiatives